Investing Completion of preclinical data package for RAD 402 December 10, 2024 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402 Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Lundin Mining to Divest Neves-Corvo and Zinkgruvan Operations for US$1.52 Billion December 10, 2024 Next Post Capital Raising and QSM Completion Update December 10, 2024 Related Posts Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 13, 2026 Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 13, 2026 Lahontan Announces Private Placement March 13, 2026
Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 13, 2026
Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 13, 2026
